Alkynes

Results: 297



#Item
111NewsBytes January 13th, 2015 The Chronicle Herald Glen Canning defends sharing explicit photo of MSVU prof International group supports call for inquiry into missing, killed native women Eskasoni woman arrested after ret

NewsBytes January 13th, 2015 The Chronicle Herald Glen Canning defends sharing explicit photo of MSVU prof International group supports call for inquiry into missing, killed native women Eskasoni woman arrested after ret

Add to Reading List

Source URL: women.gov.ns.ca

Language: English - Date: 2015-01-13 14:37:29
112Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2015-01-09 03:35:30
113Volume[removed]Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Contents Rasagiline - B Cadario

Volume[removed]Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Contents Rasagiline - B Cadario

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:27
114What’s “hot” about thermogenic agents

What’s “hot” about thermogenic agents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:31
115HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-07-25 12:30:45
116FDA Tentative Approval[removed]Efavirenz Capsules 50 mg, 100 mg, and 200 mg Aurobindo Pharma, Ltd. 1

FDA Tentative Approval[removed]Efavirenz Capsules 50 mg, 100 mg, and 200 mg Aurobindo Pharma, Ltd. 1

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2009-11-10 08:30:56
117Abstract # 1048  Phase I study of HM61713, a novel epidermal growth factor receptor (EGFR) mutant selective inhibitor, in non-small cell lung cancer (NSCLC) patients having an activating EGFR mutation but failed to prior

Abstract # 1048 Phase I study of HM61713, a novel epidermal growth factor receptor (EGFR) mutant selective inhibitor, in non-small cell lung cancer (NSCLC) patients having an activating EGFR mutation but failed to prior

Add to Reading List

Source URL: www.hanmipharm.com

Language: English - Date: 2014-03-27 02:03:41
118Astellas Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer NORTHBROOK, Ill., Nov. 20, 2012 – Astellas Pharma US, Inc. (“

Astellas Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer NORTHBROOK, Ill., Nov. 20, 2012 – Astellas Pharma US, Inc. (“

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2012-11-19 03:35:22
1196th Invitation to manufacturers of reproductive health products to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team - Medicines (October 2014)

6th Invitation to manufacturers of reproductive health products to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team - Medicines (October 2014)

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2014-10-01 03:40:22
120ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer

Add to Reading List

Source URL: dctd.cancer.gov

Language: English - Date: 2014-10-23 22:26:08